Skip to main content
. 2022 Mar 8;14(6):1133. doi: 10.3390/nu14061133

Table 3.

Repeated measures analysis of variance. Contrast of FZD7 expression between NAFLD severity and time exosomes extracted from plasma of healthy subjects and NAFLD-affected patients. NutriAtt Trial, Castellana Grotte, 2015–2016. Number of healthy subjects (NAFLD absent) = 20, number of patients affected by moderate steatosis (NAFLD moderate) = 38, and severe steatosis (NAFLD Severe) = 57. * p = 0.005.

FZD7 Contrast (CI 95%)
(90daysVs baseline)
NAFLD absent
−0.82 (−2.99; 1.35)
(90days Vs baseline)
NAFLD Moderate
−4.81 (−6.80; −2.83) *
(90days Vs baseline)
NAFLD Severe
−11.85 (−13.07; −10.62)